HeartBeam, Inc. (BEAT) intrinsic value & 10-year financials
HeartBeam, Inc. (BEAT) has no Graham intrinsic value right now because the formula needs positive earnings.
- Graham intrinsic value
- —
- Revenue (FY2025)
- —
- ROIC (10-yr avg)
- -264.4%
- Free cash flow (FY2025)
- -$14.6M
BEAT 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | — | -$21.0M | -$0.62 | -$14.6M | — | -993.1% |
| FY2024 | — | -$19.4M | -$0.73 | -$14.7M | — | -226.1% |
| FY2023 | — | -$14.6M | -$0.72 | -$12.3M | — | -167.3% |
| FY2022 | — | -$13.0M | -$1.59 | — | — | -165.1% |
| FY2021 | — | -$4.4M | -$0.52 | — | — | -53.0% |
| FY2020 | — | -$1.1M | -$0.14 | — | — | 18.5% |
| FY2019 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
HeartBeam, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
HeartBeam, Inc. has historically struggled to out-earn its cost of capital, averaging just -8.3% ROIC.
HeartBeam, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
HeartBeam, Inc. is evaluated under Benjamin Graham's defensive framework using SEC EDGAR fundamentals using an 8.5 + 2g earnings multiple and a 5.1% AAA bond-yield baseline.